VJHemOnc is committed to improving our service to you

ESH AL 2020 | ESH AL highlights: management of T-cell malignancies

VJHemOnc is committed to improving our service to you

John DiPersio

John DiPersio, MD, PhD, Washington University School of Medicine, Washington, WA, discusses emerging treatment approaches for T-cell malignancies and shares his key take-home messages from this year’s ESH AL meeting. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter